American Portfolios Advisors’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

American Portfolios Advisors’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$847	Hold	6	–	–	﹤0.01%	3296
2022 Q2	$1.01K	Hold	6	–	–	﹤0.01%	3271
2022 Q1	$1.36K	Hold	6	–	–	﹤0.01%	3304
2021 Q4	$1.42K	Hold	6	–	–	﹤0.01%	3255
2021 Q3	$1.83K	Hold	6	–	–	﹤0.01%	3191
2021 Q2	$2.51K	Hold	6	–	–	﹤0.01%	3081
2021 Q1	$2.72K	Buy	+6	New	+$2.6K	﹤0.01%	2903

Other funds holding CANF

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

American Portfolios Advisors's CANF Position: Q3 2022 in Review

American Portfolios Advisors held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q3 2022 at 6 shares worth $847. The position accounts for ﹤0.01% of the portfolio, ranked #3296.

American Portfolios Advisors first reported a position in CANF in Q1 2021 and has held it in 7 quarters since. The position peaked at $2.72K in Q1 2021. 12 funds tracked by Wall St. Rank hold CANF as of Q3 2022.

American Portfolios Advisors held 6 shares of Can-Fite BioPharma American Depositary Shares worth $847 as of Q3 2022.
American Portfolios Advisors left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q3 2022.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3296 holding.
American Portfolios Advisors first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2021 and has held it in 7 quarters since.
American Portfolios Advisors's Can-Fite BioPharma American Depositary Shares position peaked at $2.72K in Q1 2021.
12 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.